Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
An announcement from 4DMedical Ltd ( (AU:4DX) ) is now available.
4DMedical Limited has announced an investor webinar hosted by its CEO, Dr. Andreas Fouras, to discuss the recent capital raise through a Placement and Share Purchase Plan. This initiative is expected to support the company’s growth and further its mission in redefining respiratory healthcare. Stakeholders are invited to participate in this event, which indicates 4DMedical’s proactive engagement with its investor community and commitment to transparency.
More about 4DMedical Ltd
4DMedical Limited is a global leader in medical technology focused on revolutionizing respiratory care through advanced imaging and AI-powered solutions. Its patented XV Technology® allows for dynamic quantification of lung ventilation, enhancing diagnostic precision for respiratory diseases. The company operates on a Software as a Service (SaaS) model, providing tools that integrate into existing hospital infrastructure. In 2023, 4DMedical expanded its capabilities with the acquisition of Imbio, which offers AI-driven platforms for chronic lung and cardiothoracic diseases.
YTD Price Performance: 13.54%
Average Trading Volume: 898,025
Technical Sentiment Consensus Rating: Hold
Current Market Cap: A$223.6M
For a thorough assessment of 4DX stock, go to TipRanks’ Stock Analysis page.
